Steven Keith Burke, SVP, Chief Medical Officer at Akebia Therapeutics, Inc. (AKBA), sold 77,742 shares at $2.10 ($163K) on 2025-02-03, disclosed to the SEC on 2025-02-04.
Scheduled sale ($163k) by SVP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.10 | 23,270 | $49K | 29.9% |
| 2 | $2.10 | 27,236 | $57K | 35.0% |
| 3 | $2.10 | 27,236 | $57K | 35.0% |
| Total | $2.10 avg | 77,742 | $163K | 100% |
| Filing → |
| AKBA | SELL | 2024-05-09 | $31K | — | Filing → |
| AKBA | SELL | 2024-03-01 | $11K | — | Filing → |
| AKBA | SELL | 2024-02-29 | $13K | — | Filing → |